SCHEMBL838477

SCHEMBL838477

Cc1cc2ccc(OP(=O)(O)O)cc2oc1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.56
STS P08842 1/20 0.54
ALDH1A1 P00352 4/20 0.49
HPGD P15428 4/20 0.49
HSD17B10 Q99714 2/20 0.49
CYP1A2 P05177 1/20 0.49
ALOX15 P16050 1/20 0.49
MAOB P27338 6/20 0.48
CA12 O43570 2/20 0.48
CA2 P00918 2/20 0.48
CA4 P22748 2/20 0.48
CA7 P43166 2/20 0.48
CA1 P00915 1/20 0.48
CA5A P35218 1/20 0.48
CA5B Q9Y2D0 1/20 0.48
GLA P06280 4/20 0.46
GAA P10253 3/20 0.46
KDM4E B2RXH2 2/20 0.46
SLC16A3 O15427 1/20 0.46
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18486585 0.84 ACHE (0.51) HSD17B3ALDH1A1HPGDHSD17B10CYP1A2
SCHEMBL4532475 0.80 SLC16A3 (0.68) STSALDH1A1HPGDHSD17B10ALOX15
SCHEMBL1460890 0.80 GLA (0.68) STSALDH1A1HPGDHSD17B10MAOB
SCHEMBL10305766 0.80 ALDH1A1 (0.63) HSD17B3ALDH1A1HPGDHSD17B10MAOB
SCHEMBL3273965 0.79 STS (0.48) STSALDH1A1HPGDHSD17B10MAOB
SCHEMBL1871996 0.79 STS (0.48) STSALDH1A1HPGDHSD17B10MAOB
SCHEMBL1460841 0.78 CA12 (0.60) STSALDH1A1HPGDHSD17B10CYP1A2
SCHEMBL381683 0.78 NPC1 (0.67) STSALDH1A1HPGDHSD17B10MAOB
SCHEMBL4769996 0.78 KDM4E (0.67) HSD17B3ALDH1A1HPGDHSD17B10CYP1A2
SCHEMBL8425140 0.78 ALDH1A1 (0.59) HSD17B3ALDH1A1HPGDHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2181330-A1 COMPOSITIONS AND MEANS FOR DIAGNOSING MICROBIAL INFECTIONS Statens Serum Institut (DK) 2010-05-05 EP claimed
WO-2009026920-A1 COMPOSITIONS AND MEANS FOR DIAGNOSING MICROBIAL INFECTIONS STATENS SERUM INSTITUT (DK) 2009-03-05 WO claimed
US-5501952-A Analogues of reporter groups as background reducers in hybridization assays APROGENEX, INC. (US) 1996-03-26 US claimed
EP-0420186-B1 Immunoassay using magnetic particle FUJIREBIO KK (JP) 1995-08-02 EP claimed
US-5320944-A Organic polymer core and coating layer of iron oxide type ferrite FUJIREBIO INC. (JP) 1994-06-14 US claimed
EP-0452330-A4 METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM 1992-10-14 EP claimed
US-5089395-A High speed qualitative, quantitative analysis UNIVERSITY OF CINCINNATI (US) 1992-02-18 US claimed
EP-0452330-A1 METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM TOTEM HEALTH SCIENCES, INC. (CA) 1991-10-23 EP claimed
EP-0440193-A2 Immunochemical assay method with plural items FUJIREBIO INC. (JP) 1991-08-07 EP claimed
EP-0420186-A2 Immunoassay using magnetic particle FUJIREBIO INC. (JP) 1991-04-03 EP claimed
WO-1990004644-A1 METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM TOTEM HEALTH SCIENCES, INC. (CA) 1990-05-03 WO claimed
EP-4609196-A1 METHOD TO DETERMINE EXTRACELLULAR VESICLE RECOVERY Eximmium Biotechnologies GmbH (DE) 2025-09-03 EP disclosed
WO-2024089180-A1 METHOD TO DETERMINE EXTRACELLULAR VESICLE RECOVERY EXIMMIUM BIOTECHNOLOGIES GMBH (DE) 2024-05-02 WO disclosed
WO-2023074988-A1 METHOD FOR ANALYZING LIQUID IMMUNE RESPONSE USING MAGNETIC BEADS 바디텍메드(주) 2023-05-04 WO disclosed
CN-113631572-A GRP78 and/or HSP70 inhibitors for therapeutic use GHP科学有限公司 2021-11-09 CN disclosed
EP-0267690-A1 Immune complex assay VASOCOR (US) 1988-05-18 EP disclosed
US-4745077-A IMMUNOASSAY USING LABELED REAGENTS AMERSHAM INTERNATIONAL PLC. (GB) 1988-05-17 US disclosed
EP-0227795-A1 METHOD FOR PERFORMING NUCLEIC ACID HYBRIDIZATION ASSAYS. AMGEN (US) 1987-07-08 EP disclosed
WO-1986007387-A1 METHOD AND KIT FOR PERFORMING NUCLEIC ACID HYBRIDIZATION ASSAYS AMGEN (US) 1986-12-18 WO disclosed
EP-0149565-A2 Assay method Kodak Clinical Diagnostics Limited (GB) 1985-07-24 EP disclosed